AstraZeneca says its antibody drug Evusheld can fight Omicron
AstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetailsAstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetails
By Aakar Patel If all goes well, and your columnist is really hoping that it does go well, the world’s...
Read moreDetailsIt’s not every day that a Prime Minister spends hours in brainstorming sessions with senior bureaucrats. But that’s exactly what...
Read moreDetailsBy Shoumitro Chatterjee & Arvind Subramanian China’s rising trade surplus is once again causing unease in the United States and...
Read moreDetailsBrahma Chellaney During his 13 years in power, Xi Jinping has steadily tightened his grip on all levers of authority...
Read moreDetails